01 1Cadila Pharmaceuticals
01 1LORATADINE USP POWDER
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-21
Pay. Date : 2013-09-11
DMF Number : 17582
Submission : 2004-07-10
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LORATADINE USP POWDER, with a corresponding US DMF Number 17582.
Remarkably, this DMF maintains an Active status since its submission on July 10, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
